Genky DrugStores Co., Ltd. reported consolidated and non-consolidated earnings results for the year ended June 20, 2019. For the year, the consolidated company reported net sales of ¥103,897 million compared to ¥94,869 million a year ago. Operating income was ¥4,046 million compared to ¥4,128 million a year ago. Net income attributable to owners of parent was ¥2,697 million or ¥174.70 per share compared to ¥3,118 million or ¥206.55 per share a year ago.

For the year, the non-consolidated company reported net sales of ¥244 million compared to ¥122 million a year ago. Operating income was ¥8 million compared to ¥37 million a year ago. Net income was ¥6 million or ¥0.44 per share compared to ¥927 million or ¥61.40 per share a year ago.

The company provided earnings guidance for the first half and fiscal year 2020. For the first half, the company expects net sales of ¥56,500 million, operating income was ¥1,550 million and net income attributable to owners of parent of ¥1,200 million or ¥79.07 per share.

For the year ending June 20, 2019, the company expects net sales of ¥115,000 million, operating income was ¥4,050 million and net income attributable to owners of parent of ¥3,000 million or ¥197.66 per share.